BACKGROUND: To evaluate the outcomes of secondary (2o) procedures after endovascular aneurysm repair (EVAR).
METHODS: From 2002-2008, 1450 patients underwent EVAR and were evaluated by CTA every 6-12 months. Patients with type I and III endoleaks (EL), unexplained endotension, limb occlusion, stentgraft (SG) migration with and without type I endoleak, and aneurysm rupture underwent 2o interventions. Type II EL at > 6 month without decrease in the aneurysm sac underwent trans-lumbar (TL) embolization. Data was prospectively collected.
RESULTS: Of 1450 elective (n=1362, 94%) and emergent (n=88, 6%) EVAR procedures, 259 (17.9%) patients required addtional procedures over a mean follow-up of 32 months (range 1-84 months). 229 (15.8%) patients required 2o endovascular (n=200, 87%) and open surgical (n=29, 13%) proceudres (Table 1). 76% (22 of 29 patients) of aneurysm rupture patients were considered lost to follow-up after the intial EVAR. An additional 30 (2.1%) patietns required tertiary (3o) proceudres including repeat TL embolization (n=12, 0.8%), repeat proximal SG extension for migration (n=11, 0.8%), and elective open surgical repair (n=7, 0.5%). The overall mortality of these 2o and 3o procedures was 3.9%, and was highest in the aneurysm rupture group; 15% (4 of 29 patients) (Table 1).
CONCLUSIONS: Our midterm experience indicates that 18% of patients require additional 2o and 3o procedures, and vast majority of these patients can be managed by endovascular means with acceptable overall mortality of 3.9%. Most type I EL can be successfully treated by TL embolization. Most patients with delayed aneurysm rupture after EVAR can be successfully managed by endovascular or open surgical repair.
| Indication | N | 2o Procedures | Death |
| Type I EL | 39 (2.7%) | 14 (36%): Prox. SG Extension 17 (44%): TL embo. 6 (15%): Spontaneous seal 2 (5%): Open Surgical Repair | 2.(5) |
| Type II EL | 104 (7.1%) | 98 (94%) : TL embo. 6 (6%): Transfemoral embo. | 2 (2%) |
| Type III EL | 3 (0.2%) | 3 (100%): SG extension | - |
| Endotension | 12 (0.8%) | 8 (67%): SG relining 2 (17%): Open surgical repair 2 (17%): No treatment | - |
| Limb Thrombosis | 14 (1%) | 7 (50%): Fem-fem. bypass 5 (36%): SG thrombectomy 2 (14%): No treatment | 1.(7%) |
| Migration | 38 (2.6%) | 28 (74%): SG extension 10 (36%):AUI | 1 (3%) |
| Rupture | 29 (2.0%) | 15 (52%): Open surgical repair 13 (45%): EVAR 1 (3%): Refused treatment | 4 (15%) |